{ "labelLang" : "hun", "responseDate" : "2024-03-29 08:53", "content" : { "otype" : "JournalArticle", "mtid" : 23219295, "status" : "APPROVED", "published" : true, "comment" : "N1 : Chemicals/CAScarbamazepine, 298-46-4, 8047-84-5; clobazam, 22316-47-8; clonazepam, 1622-61-3; etiracetam, 102767-28-2, 33996-58-6; fluoxetine, 54910-89-3, 56296-78-7, 59333-67-4; haloperidol, 52-86-8; lamotrigine, 84057-84-1; lithium, 7439-93-2; nortriptyline, 72-69-5, 894-71-3; oxcarbazepine, 28721-07-5; perphenazine, 58-39-9; tiagabine, 115103-54-3, 115103-55-4; valproic acid, 1069-66-5, 99-66-1; Anticonvulsants; Antimanic Agents; Lithium Compounds\nMegjegyzés-23219006\nN1 : Chemicals/CAScarbamazepine, 298-46-4, 8047-84-5; clobazam, 22316-47-8; clonazepam, 1622-61-3; etiracetam, 102767-28-2, 33996-58-6; fluoxetine, 54910-89-3, 56296-78-7, 59333-67-4; haloperidol, 52-86-8; lamotrigine, 84057-84-1; lithium, 7439-93-2; nortriptyline, 72-69-5, 894-71-3; oxcarbazepine, 28721-07-5; perphenazine, 58-39-9; tiagabine, 115103-54-3, 115103-55-4; valproic acid, 1069-66-5, 99-66-1; Anticonvulsants; Antimanic Agents; Lithium Compounds\nMegjegyzés-23219167\nN1 : Chemicals/CAScarbamazepine, 298-46-4, 8047-84-5; clobazam, 22316-47-8; clonazepam, 1622-61-3; etiracetam, 102767-28-2, 33996-58-6; fluoxetine, 54910-89-3, 56296-78-7, 59333-67-4; haloperidol, 52-86-8; lamotrigine, 84057-84-1; lithium, 7439-93-2; nortriptyline, 72-69-5, 894-71-3; oxcarbazepine, 28721-07-5; perphenazine, 58-39-9; tiagabine, 115103-54-3, 115103-55-4; valproic acid, 1069-66-5, 99-66-1; Anticonvulsants; Antimanic Agents; Lithium Compounds", "unhandledTickets" : 0, "oldTimestamp" : "2018-10-01T21:49:28.000+0000", "deleted" : false, "oldId" : 13219295, "lastRefresh" : "2020-05-19T06:53:28.401+0000", "lastModified" : "2018-10-11T14:35:48.618+0000", "created" : "2013-07-24T08:30:13.000+0000", "creator" : { "otype" : "Author", "mtid" : 10005190, "link" : "/api/author/10005190", "label" : "Bitter István (Elmekórtan)", "familyName" : "Bitter", "givenName" : "István", "published" : true, "oldId" : 10005190, "snippet" : true }, "lastDuplumOK" : "2020-05-19T06:52:51.043+0000", "lastDuplumSearch" : "2020-05-19T06:52:51.043+0000", "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000059, "link" : "/api/subtype/10000059", "label" : "Szakcikk (Folyóiratcikk)", "name" : "Szakcikk", "nameEng" : "Article", "docType" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "listPosition" : 101, "published" : true, "oldId" : 10000059, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10005, "link" : "/api/language/10005", "label" : "Német", "name" : "Német", "nameEng" : "German", "published" : true, "oldId" : 5, "snippet" : true } ], "firstAuthor" : "Conca, A", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 29507628, "link" : "/api/authorship/29507628", "label" : "Conca, A", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Conca", "givenName" : "A", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 45492274, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 29507629, "link" : "/api/authorship/29507629", "label" : "Grohmann, R", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : false, "familyName" : "Grohmann", "givenName" : "R", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 45492273, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 29507630, "link" : "/api/authorship/29507630", "label" : "Di Pauli, J", "listPosition" : 3, "share" : 0.0, "first" : false, "last" : false, "familyName" : "Di Pauli", "givenName" : "J", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 45492272, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 29507631, "link" : "/api/authorship/29507631", "label" : "Hausmann, A", "listPosition" : 4, "share" : 0.0, "first" : false, "last" : true, "familyName" : "Hausmann", "givenName" : "A", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 45492271, "snippet" : true } ], "title" : "Is there a rationale in combining anticonvulsants for bipolar patients?", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 6432639, "link" : "/api/publicationidentifier/6432639", "label" : "WoS: 000247702600010", "source" : { "otype" : "PlainSource", "mtid" : 1, "link" : "/api/publicationsource/1", "label" : "WoS", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "WoS", "nameEng" : "WoS", "linkPattern" : "http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=CustomerName&SrcApp=CustomerName&DestLinkType=FullRecord&KeyUT=@@@&DestApp=WOS", "publiclyVisible" : true, "published" : true, "oldId" : 1, "snippet" : true }, "validState" : "NO", "idValue" : "000247702600010", "realUrl" : "http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=CustomerName&SrcApp=CustomerName&DestLinkType=FullRecord&KeyUT=000247702600010&DestApp=WOS", "published" : false, "oldId" : 7336949, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 6432640, "link" : "/api/publicationidentifier/6432640", "label" : "Scopus: 34447249748", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "NO", "idValue" : "34447249748", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-34447249748", "published" : false, "oldId" : 3534394, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 6432641, "link" : "/api/publicationidentifier/6432641", "label" : "PubMed: 17640500", "source" : { "otype" : "PlainSource", "mtid" : 17, "link" : "/api/publicationsource/17", "label" : "PubMed", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "PubMed", "nameEng" : "PubMed", "linkPattern" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract", "publiclyVisible" : true, "published" : true, "oldId" : 17, "snippet" : true }, "validState" : "NO", "idValue" : "17640500", "realUrl" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17640500&dopt=Abstract", "published" : false, "oldId" : 3534395, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 19593, "link" : "/api/journal/19593", "label" : "NEUROPSYCHIATRIE 0948-6259", "pIssn" : "0948-6259", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "hungarian" : false, "published" : true, "oldId" : 19593, "snippet" : true }, "volume" : "21", "issue" : "2", "firstPage" : "159", "lastPage" : "171", "firstPageOrInternalIdForSort" : "159", "pageLength" : 13, "publishedYear" : 2007, "digital" : null, "printed" : null, "sourceYear" : 2013, "packet" : "(Bitter István (Elmekórtan); 2013.07.24. 10:26:37)", "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : null, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2020-05-19", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 5, "citedCount" : 5, "ratings" : [ { "otype" : "SjrRating", "mtid" : 5901655, "link" : "/api/sjrrating/5901655", "label" : "sjr:Q3 (2007) Scopus - Clinical Psychology NEUROPSYCHIATRIE 0948-6259", "listPos" : 165, "rankValue" : 0.74, "type" : "journal", "ratingType" : { "otype" : "RatingType", "mtid" : 10002, "link" : "/api/ratingtype/10002", "label" : "sjr", "code" : "sjr", "published" : true, "snippet" : true }, "subject" : { "otype" : "ClassificationExternal", "mtid" : 3203, "link" : "/api/classificationexternal/3203", "label" : "Scopus - Clinical Psychology", "published" : true, "oldId" : 3203, "snippet" : true }, "ranking" : "Q3", "calculation" : "DIRECT", "published" : true, "oldId" : 5901655, "snippet" : true } ], "ratingsForSort" : "Q3", "referenceList" : "Amann, B., Grunze, H., Neurochemical underpinnings in bipolar disorder and epilepsy (2005) Epilepsia, 46, pp. 26-30; \n\n(2002) Practice guideline for the treatment of patients with bipolar disorder (revision), , American Psychiatric Association, Copyright, American Psychiatric Association; \n\nBaethge, C., Baldessarini, R.J., Mathiske-Schmidt, K., Hennen, J., Berghofer, A., Muller-Oerlinghausen, B., Bschor, T., Bauer, M., Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients (2005) J Clin Psychiatry, 66, pp. 174-182; \n\nBauer, M.S., Mitchner, L., What is a \"mood stabilizer\"? An evidence-based response (2004) Am J Psychiatry, 161, pp. 3-18; \n\nBauer, M.S., Altshuler, L., Evans, D.R., Beresford, T., Williford, W.O., Hauger, R.V.A., Cooperative Study #430 Team Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder (2005) J Affect Disord, 85, pp. 301-315; \n\nBook, S.W., Myrick, H., Novel anticonvulsants in the treatment of alcoholism (2005) Expert Opin Investig Drugs, 14, pp. 371-376; \n\nBraunig, P., Kruger, S., Levetiracetam in the treatment of rapid cycling bipolar disorder (2003) J Psychopharmacol, 17, pp. 239-241; \n\nBreese, G.R., Overstreet, D.H., Knapp, D.J., Conceptual framework for the etiology of alcoholism: A \"kindling\"/stress hypothesis (2005) Psychopharmacology, 178, pp. 367-380; \n\nDenicoff, K.D., Smith-Jackson, E.E., Disney, E.R., Ali, S.O., Leverich, G.S., Post, R.M., Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder (1997) J Clin Psychiatry, 58, pp. 470-478; \n\nDenicoff, K.D., Smith-Jackson, E.E., Bryan, A.L., Ali, S.O., Post, R.M., Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder (1997) Am J Psychiatry, 154, pp. 1456-1458; \n\nEvins, A.E., Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders (2003) J Clin Psychiatry, 64, pp. 9-14; \n\nFile, S.E., Wilks, L.J., Effects of sodium phenobarbital on motor activity and exploration in the mouse: Development of tolerance and incidence of withdrawal responses (1990) Pharmacol Biochem Behav, 35, pp. 317-320; \n\nFrye, M.A., Ketter, T.A., Leverich, G.S., Huggins, T., Lantz, C., Denicoff, K.D., Post, R.M., The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study (2000) J Clin Psychiatry, 61, pp. 9-15; \n\nGajwani, P., Forsthoff, A., Muzina, D., Amann, B., Gao, K., Elhaj, O., Calabrese, J.R., Grunze, H., Antiepileptic drugs in mood-disordered patients (2005) Epilepsia, 46, pp. 38-44; \n\nGoldberg, J.F., Burdick, K.E., Cognitive side effects of anticonvulsants (2001) J Clin Psychiatry, 62, pp. 27-33; \n\nGoldberg, J.F., Truman, C.J., Antidepressant-induced mania: An overview of current controversies (2003) Bipolar Disord, 5, pp. 407-420; \n\nGoodwin, F.K., Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder (2003) J Clin Psychiatry, 64, pp. 18-24; \n\nGoodwin, G.M., Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: Recommendations from the British Association for Psychopharmacology (2003) J Psychopharmacol, 17, pp. 149-173; \n\nGrohmann, R., Engel, R.R., Ruther, E., Hippius, H., The AMSP drug safety program: Methods and global results (2004) Pharmacopsychiatry, 37, pp. 4-11; \n\nGrunze, H., Kasper, S., Goodwin, G., Bowden, C., Baldwin, D., Licht, R., Vieta, E., Moller, H.J., World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Bipolar Disorders.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression (2002) World J Biol Psychiatry, 3, pp. 115-124; \n\nGrunze, H., Kasper, S., Goodwin, G., Bowden, C., Baldwin, D., Licht, R.W., Vieta, E., Moller, H.J., WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania (2003) World J Biol Psychiatry, 4, pp. 5-13; \n\nGrunze, H., Kasper, S., Goodwin, G., Bowden, C., Moller, H.J., WFSBP Task Force on Treatment Guidelines for Bipolar Disorders.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: Maintenance treatment (2004) World J Biol Psychiatry, 5, pp. 120-135; \n\nHausmann, A., Weiss, U., Strauss, R., Conca, A., Sind Antispychotika Phasenprophylaktika Psychiatrie und (2005) Psychotherapie, 1-2, pp. 77-91; \n\nHemminki, E., Polypharmacy among psychiatric patients (1977) Acta Psychiatr Scand, 56, pp. 347-356; \n\nInoue, K., Arima, S., Tanaka, K., Fukui, Y., Kato, N., A lithium and carbamazepine combination in the treatment of bipolar disorder-a preliminary report (1981) Folia Psychiatr Neurol Jpn, 35, pp. 465-475; \n\nKasper, S., Haushofer, M., Zapotoczky, H.G., Aschauer, H., Wolf, R., Hinterhuber, H., Bonelli, M., Wuschitz, A., Konsensus-Statement: Diagnostik und Therapie der bipolaren Störungen (1999) Neuropsychiatrie, 13, pp. 100-108; \n\nKessing, L.V., Hansen, M.G., Andersen, P.K., Angst, J., The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders - a life-long perspective (2004) Acta Psychiatr Scand, 109, pp. 339-344; \n\nKupfer, D.J., Frank, E., Grochocinski, V.J., Cluss, P.A., Houck, P.R., Stapf, D.A., Demographic and clinical characteristics of individuals in a bipolar disorder case registry (2002) J Clin Psychiatry, 63, pp. 120-125; \n\nLykouras, L., Hatzimanolis, J., Adjunctive topiramate in the maintenance treatment of bipolar disorders: An open-label study (2004) Curr Med Res Opin, 20, pp. 843-847; \n\nLira, P.Z., Tunis, S.L., Edell, W.S., Jensik, S.E., Tohen, M., Medication prescribing patterns for patients with bipolar I disorder in hospital settings: Adherence to published practice guidelines (2001) Bipolar Disord, 3, pp. 165-173; \n\nLoscher, W., Mechanisms of drug resistance (2005) Epileptic Disord, 7, pp. 3-9; \n\nLuszczki, J.J., Czuczwar, M., Kis, J., Krysa, J., Pasztelan, I., Swiader, M., Czuczwar, S.J., Interactions of lamotrigine with topiramate and first-generation antiepileptic drugs in the maximal electroshock test in mice: An isobolographic analysis (2003) Epilepsia, 44, pp. 1003-1013; \n\nLuszczki, J.J., Czuczwar, S.J., Preclinical profile of combinations of some second-generation antiepileptic drugs: An isobolographic analysis (2004) Epilepsia, 45, pp. 895-907; \n\nLuszczki, J.J., Andres, M.M., Czuczwar, P., Cioczek-Czuczwar, A., Wojcik-Cwikla, J., Ratnaraj, N., Patsalos, P.N., Czuczwar, S.J., Levetiracetam selectively potentiates the acute neurotoxic effects of topiramate and carbamazepine in the rotarod test in mice (2005) Eur Neuropsychopharmacol, 15, pp. 609-616; \n\nMaj, M., Pirozzi, R., Magliano, L., Bartoli, L., The prognostic significance of \"switching\" in patients with bipolar disorder: A 10-year prospective follow-up study (2002) Am J Psychiatry, 159, pp. 1711-1717; \n\nMalhi, G.S., Mitchell, P.B., Salim, S., Bipolar depression: Management options (2003) CNS Drugs, 17, pp. 9-25; \n\nMcIntyre, R.S., Konarski, J.Z., Yatham, L.N., Comorbidity in bipolar disorder: A framework for rational treatment selection (2004) Hum Psychopharmacol, 19, pp. 369-386; \n\nMulsant, B.H., Alexopoulos, G.S., Reynolds 3rd, C.F., Katz, I.R., Abrams, R., Oslin, D., Schulberg, H.C., PROSPECT Study Group. Pharmacological treatment of depression in older primary care patients: The PROSPECT algorithm (2001) Int J Geriatr Psychiatry, 16, pp. 585-592; \n\nNonaka, S., Katsube, N., Chuang, D.M., Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine (1998) J Pharmacol Exp Ther, 286, pp. 539-547; \n\nPachet, A.K., Wisniewski, A.M., The effects of lithium on cognition: An updated review (2003) Psychopharmacology, 170, pp. 225-234; \n\nPande, A.C., Davidson, J.R., Jefferson, J.W., Janney, C.A., Katzelnick, D.J., Weisler, R.H., Greist, J.H., Sutherland, S.M., Treatment of social phobia with gabapentin: A placebo-controlled study (1999) J Clin Psychopharmacol, 19, pp. 341-348; \n\nPande, A.C., Crockatt, J.G., Janney, C.A., Werth, J.L., Tsaroucha, G., Gabapentin in bipolar disorder: A placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group (2000) Bipolar Disord, 2, pp. 249-255; \n\nPande, A.C., Pollack, M.H., Crockatt, J., Greiner, M., Chouinard, G., Lydiard, R.B., Taylor, C.B., Shiovitz, T., Placebo-controlled study of gabapentin treatment of panic disorder (2000) J Clin Psychopharmacol, 20, pp. 467-471; \n\nPerucca, E., Overtreatment in epilepsy: Adverse consequences and mechanisms (2002) Epilepsy Res, 52, pp. 25-33; \n\nPies, R., Combining lithium and anticonvulsants in bipolar disorder: A review (2002) Ann Clin Psychiatry, 14, pp. 223-232; \n\nPost, R.M., Leverich, G.S., Denicoff, K.D., Frye, M.A., Kimbrell, T.A., Dunn, R., Alternative approaches to refractory depression in bipolar illness (1997) Depress Anxiety, 5, pp. 175-189; \n\nPost, R.M., Leverich, G.S., Altshuler, L.L., Frye, M.A., Suppes, T.M., Keck Jr., P.E., McElroy, S.L., Walden, J., An overview of recent findings of the Stanley Foundation Bipolar Network (Part I) (2003) Bipolar Disord, 5, pp. 310-319; \n\nPost, R.M., Denicoff, K.D., Leverich, G.S., Altshuler, L.L., Frye, M.A., Suppes, T.M., Rush, A.J., Nolen, W.A., Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method (2003) J Clin Psychiatry, 64, pp. 680-690; \n\nPost, R.M., Altshuler, L.L., Frye, M.A., Suppes, T., McElroy, S.L., Keck Jr., P.E., Leverich, G.S., Grunze, H., Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder (2005) J Clin Psychiatry, 66, pp. 370-374; \n\nReijs, R., Aldenkamp, A.P., De Krom, M., Mood effects of antiepileptic drugs (2004) Epilepsy Behav, 5, pp. 66-76; \n\nRickels, K., Pollack, M.H., Feltner, D.E., Lydiard, R.B., Zimbroff, D.L., Bielski, R.J., Tobias, K., Pande, A.C., Pregabalin for treatment of generalized anxiety disorder: A 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam (2005) Arch Gen Psychiatry, 62, pp. 1022-1030; \n\nRittmannsberger, H., The use of drug monotherapy in psychiatric inpatient treatment (2002) Prog Neuropsychopharmacol Biol Psychiatry, 26, pp. 547-551; \n\nRittmannsberger, H., Polypharmacy in psychiatric inpatient treatment (2004) Am J Psychiatry, 161, p. 761; \n\nRogawski, M.A., Loscher, W., The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions (2004) Nat Med, 10, pp. 685-692; \n\nRoyal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder. Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder. Aust N Z J Psychiatry 38, 280-305 2004Sachs, G.S., Decision tree for the treatment of bipolar disorder (2003) J Clin Psychiatry, 64, pp. 35-40; \n\nSalloum, I.M., Cornelius, J.R., Daley, D.C., Kirisci, L., Himmelhoch, J.M., Thase, M.E., Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: A double-blind placebo-controlled study (2005) Arch Gen Psychiatry, 62, pp. 37-45; \n\nSills, G.J., Butler, E., Thompson, G.G., Brodie, M.J., Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models (2004) Seizure, 13, pp. 287-295; \n\nSimon, N.M., Otto, M.W., Wisniewski, S.R., Fossey, M., Sagduyu, K., Frank, E., Sachs, G.S., Pollack, M.H., Anxiety disorder comorbidity in bipolar disorder patients: Data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) (2004) Am J Psychiatry, 161, pp. 222-229; \n\nSolomon, D.A., Ryan, C.E., Keitner, G.I., Miller, I.W., Shea, M.T., Kazim, A., Keller, M.B., A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar 1 disorder (1997) J Clin Psychiatry, 58, pp. 95-99; \n\nSun, M., van Rijn, C.M., Liu, Y., Wang, M., Combination of carbamazepine and valproate in different dose proportions in maximal electroshock seizure model in mice (2002) Epilepsy Res, 51, pp. 5-11; \n\nXamayo, J., Zarate, C., Vieta, E., Tohen, M., Medications for bipolar disorders: A review of their therapeutic and pharmacological differences. Part II: from sinapse to genes (2004) Actas Esp Psiquiatr, 32, pp. 18-37; \n\nTurnheim, K., Drug interactions with antiepileptic agents (2004) Wien Klin Wochenschr, 116, pp. 112-118; \n\nVan Gorp, W.G., Altschuler, L., Theberge, D.C., Wilkins, J., Dixon, W., Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence (1998) Arch Gen Psychiatry, 55, pp. 41-46; \n\nVestergaard, P., Guidelines for maintenance treatment of bipolar disorder: Are there discrepancies between European and North American recommendations? (2004) Bipolar Disord, 6, pp. 519-522; \n\nVieta, E., Goikolea, J.M., Olivares, J.M., Gonzalez-Pinto, A., Rodriguez, A., Colom, F., Comes, M., Sanchez-Moreno, J., 1-year follow-up of patients treated with risperidone and topiramate for a manic episode (2003) J Clin Psychiatry, 64, pp. 834-839; \n\nVieta, E., Sanchez-Moreno, J., Goikolea, J.M., Torrent, C., Benabarre, A., Colom, F., Martinez-Aran, A., Corbella, B., Adjunctive topiramate in bipolar II disorder (2003) World J Biol Psychiatry, 4, pp. 172-176; \n\nViola, R., Csukonyi, K., Doro, P., Janka, Z., Soos, G., Reasons for polypharmacy among psychiatric patients (2004) Pharm World Sci, 26, pp. 143-147; \n\nWhite, J.R., Walczak, T.S., Leppik, I.E., Rarick, J., Tran, T., Beniak, T.E., Matchinsky, D.J., Gumnit, R.J., Discontinuation of levetiracetam because of behavioral side effects: A case-control study (2003) Neurology, 61, pp. 1218-1221; \n\nYoung, L.T., Joffe, R.T., Robb, J.C., MacQueen, G.M., Marriott, M., PatelisSiotis, I., Double-blind comparison of addition of a second mood-stabilizer versus an antidepressant to an initial mood-stabilizer for treatment of patients with bipolar depression (2000) Am J Psychiatry, 157, pp. 124-126; \n\nZarate Jr., C.A., Quiroz, J.A., Combination treatment in bipolar disorder: A review of controlled trials (2003) Bipolar Disord, 5, pp. 217-225; \n\nZhang, Z.J., Russell, S., Obeng, K., Postma, T., Obrocea, G., Weiss, S.R., Post, R.M., Coadministration of gabapentin or MK-801 with lamotrigine slows tolerance to its anticonvulsant effects on kindled seizures (2003) Pharmacol Biochem Behav, 74, pp. 565-571; \n\nZhang, Z.J., Xing, G.Q., Russell, S., Obeng, K., Post, R.M., Unidirectional cross-tolerance from levetiracetam to carbamazepine in amygdala-kindled seizures (2003) Epilepsia, 44, pp. 1487-1493", "hasCitationDuplums" : false, "userChangeableUntil" : "2013-10-22T11:24:44.000+0000", "publishDate" : "2013-07-24T11:24:44.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 6, "ownerInstituteCount" : 23, "directInstituteCount" : 0, "authorCount" : 4, "contributorCount" : 0, "hasQualityFactor" : true, "link" : "/api/publication/23219295", "label" : "Conca A et al. Is there a rationale in combining anticonvulsants for bipolar patients?. (2007) NEUROPSYCHIATRIE 0948-6259 21 2 159-171", "template" : "